Adelaide Research & Scholarship: Search

Search

Results 1-10 of 14 (Search time: 0.002 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2009	Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation	Degenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
	2007	Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadon	Coller, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
	2005	Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project	Digiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
	2005	Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects	Hanna, J.; Foster, D.; Salter, A.; Somogyi, A.; White, J.; Bochner, F.
	2005	The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)	Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
	2009	The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio	Bell, J.; Shearer, J.; Ryan, A.; Graham, R.; Korompay, K.; Rizzo, S.; Sindhusake, D.; Somogyi, A.
	2008	Antinociceptive effects of high dose remifentanil in male methadone-maintained patients	Hay, J.; White, J.; Bochner, F.; Somogyi, A.
	2008	Electrocardiogram characteristics of methadone and buprenorphine maintained subjects	Athanasos, P.; Farquharson, A.; Compton, P.; Psaltis, P.; Hay, J.
	2001	The relationship between mood state and plasma methadone concentration in maintenance patients	Dyer, K.; White, J.; Foster, D.; Bochner, F.; Menelaou, A.; Somogyi, A.
	2006	ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals	Coller, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.